Antibiotic resistance in hospital-acquired ESKAPE-E infections in low- and lower-middle-income countries: a systematic review and meta-analysis

References

• Ahmad M, Khan AU. Global economic impact of antibiotic resistance: a review. J Glob Antimicrob Resist. 2019;19:313–316.
   PubMed Web of Science ®Google Scholar
• Tacconelli E, Carrara E, Savoldi A, et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis. 2018 Mar;18(3):318–327.
   PubMed Web of Science ®Google Scholar
• Tabah A, Koulenti D, Laupland K, et al. Characteristics and determinants of outcome of hospital-acquired bloodstream infections in intensive care units: the EUROBACT International cohort study. Intensive Care Med. 2012;38(12):1930–1945.
   PubMed Web of Science ®Google Scholar
• Laxminarayan R, Matsoso P, Pant S, et al. Access to effective antimicrobials: a worldwide challenge. Lancet. 2016 Jan 9;387(10014):168–175.
   PubMed Web of Science ®Google Scholar
• Allegranzi B, Bagheri Nejad S, Combescure C, et al. Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis. Lancet. 2011 Jan 15;377(9761):228–241.
   PubMed Web of Science ®Google Scholar
• Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ (Clinical Research ed) 2021;2021(372):n71.
   Google Scholar
• World Bank. World Bank country and lending groups 2021; 2021 Aug 20. Available from: https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups.
   Google Scholar
• Cochrane Community. Covidence 2020; 2020 Oct 23. Available from: https://community.cochrane.org/help/tools-and-software/covidence.
   Google Scholar
• Barendregt JJ, Doi SA, Lee YY, et al. Meta-analysis of prevalence. J Epidemiol Community Health. 2013;67(11):974.
   PubMed Web of Science ®Google Scholar
• van Houwelingen HC, Arends LR, Stijnen T. Advanced methods in meta-analysis: multivariate approach and meta-regression. Stat Med. 2002 Feb 28;21(4):589–624.
   PubMed Web of Science ®Google Scholar
• Team RC. R: a language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2021 [cited 2021 August 24]. Available from: http://www.R-project.org.
   Google Scholar
• Guido Schwarzer JRC, Rücker G. Meta-analysis with R. Springer International Publishing. Basel; 2015.
   Google Scholar
• Viechtbauer W. Conducting meta-analyses in R with the metafor package. J Stat Softw. 2010;36(3):1–48.
   Web of Science ®Google Scholar
• Ahoyo TA, Bankole HS, Adeoti FM, et al. Prevalence of nosocomial infections and anti-infective therapy in Benin: results of the first nationwide survey in 2012. Antimicrob Resist Infect Control. 2014;3. https://doi.org/10.1186/2047-2994-3-17
   PubMed Web of Science ®Google Scholar
• Labi AK, Obeng-Nkrumah N, Owusu E, et al. Multi-centre point-prevalence survey of hospital-acquired infections in Ghana. J Hosp Infect. 2019;101(1):60–68.
   PubMed Web of Science ®Google Scholar
• Agmy G, Mohamed S, Gad Y, et al. Bacterial profile, antibiotic sensitivity and resistance of lower respiratory tract infections in upper Egypt. Mediterr J Hematol Infect Dis. 2013;5(1):1–7.
   Google Scholar
• Ahmed F, Fayza F. Bacterial pattern and risk factors of hospital acquired infections in a tertiary care hospital, Egypt. 2018. p. 9–16.
   Google Scholar
• Amutha B, Viswanathan T. Incidences of staphylococcus species in surgical site infections-prospective study from tertiary care center, Coimbatore. Tamilnadu. Int J Pharm Pharm Sci. 2015;7(5):225–228.
   Google Scholar
• Bhadade R, Harde M, desouza R, et al. Emerging Trends of Nosocomial pneumonia in intensive care unit of a tertiary care public teaching hospital in Western India. Ann Afr Med. 2017;16(3):107–113.
   PubMed Web of Science ®Google Scholar
• El-Sahrigy SAF, Shouman MG, Ibrahim HM, et al. Prevalence and anti-microbial susceptibility of hospital acquired infections in two pediatric intensive care units in Egypt. Open Access Macedonian J Med Sci. 2019;7(11):1744–1749.
   PubMedGoogle Scholar
• Moemen D, Tawfeek D, Badawy W. Healthcare-associated vancomycin resistant Enterococcus faecium; infections in the Mansoura University Hospitals intensive care units, Egypt. Braz j Microbiol. 2015;46(3):777–783.
   PubMed Web of Science ®Google Scholar
• El-Mekes A, Zahlane K, Said LA, et al. The clinical and epidemiological risk factors of infections due to multi-drug resistant bacteria in an adult intensive care unit of University Hospital Center in Marrakesh-Morocco. J Infect Public Health. 2020;13(4):637–643.
   PubMed Web of Science ®Google Scholar
• Peters L, Olson L, Khu DTK, et al. Multiple antibiotic resistance as a risk factor for mortality and prolonged hospital stay: a cohort study among neonatal intensive care patients with hospital-acquired infections caused by Gram-negative bacteria in Vietnam. Plos One. 2019;14(5).
   Web of Science ®Google Scholar
• Chaari A, Mnif B, Bahloul M, et al. Acinetobacter baumannii ventilator-associated pneumonia: epidemiology, clinical characteristics, and prognosis factors. Int J Infect Dis. 2013;17(12):E1225–E1228.
   PubMed Web of Science ®Google Scholar
• Vijayanarayana K, Rau NR, Naik NA, et al. An appraisal of sensitivity and resistance pattern of organisms isolated from hospital acquired pneumonia patients. research. J Pharm Biol Chem Sci. 2014;5(4):384–398.
   Google Scholar
• Klein EY, Van Boeckel TP, Martinez EM, et al. Global increase and geographic convergence in antibiotic consumption between 2000 and 2015. Proc Natl Acad Sci USA. 2018;115(15):E3463–E3470.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Global antimicrobial resistance and use surveillance system (GLASS) report 2021. Geneva: WHO; 2021.
   Google Scholar
• World Health Organization. Antimicrobial resistance global report on surveillance: 2014 summary. World Health Organization. Geneva; 2014.
   Google Scholar
• World Health Organisation. WHO report on surveillance of antibiotic consumption: 2016-2018 early implementation. Geneva: WHO; 2018.
   Google Scholar
• Klein EY, Milkowska-Shibata M, Tseng KK, et al. Assessment of WHO antibiotic consumption and access targets in 76 countries, 2000–15: an analysis of pharmaceutical sales data. Lancet Infect Dis. 2021;21(1):107–115.
   PubMed Web of Science ®Google Scholar
• Mbwasi R, Mapunjo S, Wittenauer R, et al. National consumption of antimicrobials in Tanzania: 2017-2019. Front Pharmacol. 2020;11:1667.
   Web of Science ®Google Scholar
• Nordmann P, Naas T, Poirel L. Global spread of carbapenemase-producing enterobacteriaceae. Emerg Infect Dis. 2011 Oct;17(10):1791–1798.
   PubMed Web of Science ®Google Scholar
• Laxminarayan R, Duse A, Wattal C, et al. Antibiotic resistance — the need for global solutions. Lancet Infect Dis. 2013;13(12):1057–1098.
   PubMed Web of Science ®Google Scholar
• Cox JA, Vlieghe E, Mendelson M, et al. Antibiotic stewardship in low- and middle-income countries: the same but different? Clin Microbiol Infect. 2017;23(11):812–818.
   PubMed Web of Science ®Google Scholar
• Broccoli MC, Pigoga JL, Nyirenda M, et al. Essential medicines for emergency care in Africa. Afr J Emerg Med. 2018;8(3):110–117.
   PubMed Web of Science ®Google Scholar
• Tartari E, Tomczyk S, Pires D, et al. Implementation of the infection prevention and control core components at the national level: a global situational analysis. J Hosp Infect. 2021;108:94–103.
   PubMed Web of Science ®Google Scholar
• Lee H, Yoon E-J, Kim D, et al. Antimicrobial resistance of major clinical pathogens in South Korea, May 2016 to April 2017: first one-year report from Kor-GLASS. Eurosurveillance. 2018;23(42):1800047.
   Web of Science ®Google Scholar
• Ham DC, See I, Novosad S, et al. Investigation of hospital-onset methicillin-resistant Staphylococcus aureus bloodstream infections at eight high burden acute care facilities in the United States, 2016. J Hosp Infect. 2020 Apr 10;105:502–508.
   Web of Science ®Google Scholar
• European Centre for Disease Prevention and Control. Antimicrobial resistance in the EU/EEA (EARS-Net): annual epidemiological report for 2019. Stockholm: ECDC; 2020.
   Google Scholar
• Unni S, Siddiqui TJ, Bidaisee S. Reduced Susceptibility and resistance to vancomycin of Staphylococcus aureus: a review of global Incidence patterns and related genetic mechanisms. Cureus. 2021;13(10):e18925–e18925.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Antibiotic resistance & patient safety portal: antibiotic resistance. Atlanta: CDC; 2021 Aug 29; Available from: https://arpsp.cdc.gov/profile/antibiotic-resistance?tab = antibiotic-resistance.
   Google Scholar
• Japanese Ministry of Health Law. Japan Nosocomial Infections Surveillance (JANIS): annual open report 2020. 2021.
   Google Scholar
• Liang Y, Qiu L, Zheng X, et al. Trend in antimicrobial resistance of Staphylococcus aureus: results from the China Antimicrobial surveillance Network (CHINET) in the last 15-year-period reports (2005-2019). Infect Drug Resist. 2021;14:2179–2181.
   PubMed Web of Science ®Google Scholar
• Ayobami O, Willrich N, Reuss A, et al. The ongoing challenge of vancomycin-resistant Enterococcus faecium and Enterococcus faecalis in Europe: an epidemiological analysis of bloodstream infections. Emerg Microbes Infect. 2020;9(1):1180–1193.
   PubMed Web of Science ®Google Scholar
• Markwart R, Saito H, Harder T, et al. Epidemiology and burden of sepsis acquired in hospitals and intensive care units: a systematic review and meta-analysis. Intensive Care Med. 2020 Aug;46(8):1536–1551.
   PubMed Web of Science ®Google Scholar
• Brinkwirth S, Ayobami O, Eckmanns T, et al. Hospital-acquired infections caused by enterococci: a systematic review and meta-analysis, WHO European region, 1 January 2010 to 4 February 2020. Eurosurveillance. 2021;26(45):2001628.
   Web of Science ®Google Scholar
• Collignon P, Beggs JJ, Walsh TR, et al. Anthropological and socioeconomic factors contributing to global antimicrobial resistance: a univariate and multivariable analysis. The Lancet Planetary Health. 2018;2(9):e398–e405.
   PubMedGoogle Scholar
• Humphries RM, Abbott AN, Hindler JA. Understanding and addressing CLSI breakpoint revisions: a primer for clinical laboratories. J Clin Microbiol. 2019;57(6):e00203–19.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Global action plan on antimicrobial resistance. Geneva; 2015.
   Google Scholar
• Pan American Health Organization. Latin American network for antimicrobial resistance surveillance (RELAVRA): AMR trends analysis. Washington (DC): PAHO; 2016.
   Google Scholar
• Hu F, Zhu D, Wang F, et al. Current status and trends of antibacterial resistance in China. Clin Infect Dis. 2018 Nov 13;67(suppl_2):S128–S134.
   PubMed Web of Science ®Google Scholar